Tracon Pharma Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (1)

Latest Posts

About This Stock More About This Stock
Week In Review: Ally Bridge Leads $140 Million Of Investments In Three Medical Device Companies
Article By: ChinaBio® Today
Saturday, December 21, 2019 5:09 PM EST
Ally Bridge Group, a Hong Kong-New York life science investment firm, announced it has led $140 million of investments in three new medical device companies, bringing its 18-month total to more than $500 million in private life science companies.
In this article: BGNE, TCON
Read
Week In Review: China Green Lights Nasdaq-Style Exchange For Young Companies
Article By: ChinaBio® Today
Saturday, January 26, 2019 4:11 PM EST
China has given the green light to a new registration-based Shanghai stock exchange aimed at high tech companies that will be less regulated than other China exchanges. The new exchange resembles Nasdaq with its dealer-to-dealer pricing mechanism.
In this article: CIR, BABA, KANG, TCON
Read
Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks
Article By: ChinaBio® Today
Saturday, December 1, 2018 4:44 PM EST
BeiGene of Beijing announced cancer drug deals worth up to $1.3 billion with Vancouver's Zymeworks. BeiGene will acquire Asian rights to two bispecific antibodies from Zymeworks and will have rights to three to-be-discovered bispecific candidates.
In this article: LLY, HCM, BGNE, MGNX, ZLAB, TCON, ZYME, BHVN
Read

PARTNER HEADLINES

Latest Tweets for $TCON

No tweets yet!